DeepMed Research

FRED HUTCHINSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: https://www.fredhutch.org

Clinical Trials

FlaxFx, A Research Study of the Effects of Flaxseed Lignans on Colon Health

Not Applicable

Completed

Conditions: Healthy

Interventions: Dietary Supplement: Flaxseed Lignans

First Posted Date: 2012-06-14

Last Posted Date: 2017-09-13

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 66

Registration Number: NCT01619020

Locations: 🇺🇸
FHCRC, Seattle, Washington, United States

Bandage Lenses in Treating Patients With Ocular Graft-Versus-Host Disease

Phase 2

Completed

Conditions: Graft Versus Host Disease
Ophthalmologic Complications

Interventions: Biological: graft versus host disease prophylaxis/therapy
Other: questionnaire administration
Procedure: optical coherence tomography

First Posted Date: 2012-06-11

Last Posted Date: 2017-07-17

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 20

Registration Number: NCT01616056

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS

Phase 2

Terminated

Conditions: Adult Acute Megakaryoblastic Leukemia (M7)
Adult Acute Monoblastic Leukemia (M5a)
Adult Erythroleukemia (M6a)
Adult Pure Erythroid Leukemia (M6b)
Adult Acute Monocytic Leukemia (M5b)
Adult Acute Myeloblastic Leukemia Without Maturation (M1)
Refractory Anemia With Excess Blasts
Adult Acute Myelomonocytic Leukemia (M4)
Recurrent Adult Acute Myeloid Leukemia
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities

Interventions: Drug: decitabine
Drug: idarubicin
Drug: cytarabine

First Posted Date: 2012-05-30

Last Posted Date: 2017-03-31

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 7

Registration Number: NCT01607645

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant

Phase 3

Completed

Conditions: Depression
Myelodysplastic Syndrome
Cancer Survivor
Hematopoietic and Lymphoid Cell Neoplasm

Interventions: Other: Internet-Based Intervention
Other: Medical Chart Review
Other: Questionnaire Administration
Other: Quality-of-Life Assessment

First Posted Date: 2012-05-18

Last Posted Date: 2020-07-31

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 1600

Registration Number: NCT01602211

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States

and more 3 locations

Crohn's Allogeneic Transplant Study

Phase 2

Terminated

Conditions: Crohn Disease

Interventions: Procedure: Allogeneic Bone Marrow Transplantation
Drug: Cyclophosphamide
Drug: Fludarabine Phosphate
Other: Laboratory Biomarker Analysis
Drug: Mycophenolate Mofetil
Drug: Mycophenolic Acid
Other: Quality-of-Life Assessment
Drug: Tacrolimus
Radiation: Total-Body Irradiation

First Posted Date: 2012-04-04

Last Posted Date: 2020-02-17

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 2

Registration Number: NCT01570348

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Phase 2

Completed

Conditions: Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
Secondary Myelodysplastic Syndromes
Acute Myeloid Leukemia With Multilineage Dysplasia
Secondary Acute Myeloid Leukemia
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Adult Acute Myeloid Leukemia With Del(5q)
Previously Treated Myelodysplastic Syndromes
Untreated Adult Acute Myeloid Leukemia
de Novo Myelodysplastic Syndromes

Interventions: Drug: tosedostat
Drug: decitabine
Drug: cytarabine

First Posted Date: 2012-03-30

Last Posted Date: 2017-02-15

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 34

Registration Number: NCT01567059

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Partnership for a Hispanic Diabetes Prevention Program

Not Applicable

Completed

Conditions: Diabetes
Pre-diabetes

Interventions: Behavioral: Home Health Party

First Posted Date: 2012-03-28

Last Posted Date: 2015-03-06

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 430

Registration Number: NCT01564797

PATH Partnering to Achieve Tobacco-free Health

Phase 1

Completed

Conditions: Smoking Cessation

Interventions: Other: Acceptance & Commitment Therapy (ACT)
Other: Cognitive Behavioral Therapy (CBT)

First Posted Date: 2012-02-16

Last Posted Date: 2016-06-17

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 450

Registration Number: NCT01533974

Locations: 🇺🇸
Group Health Cooperative, Seattle, Washington, United States

Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

Phase 2

Completed

Conditions: Aggressive Non-Hodgkin Lymphoma
Blasts Under 5 Percent of Bone Marrow Nucleated Cells
Loss of Chromosome 17p
Recurrent Adult Acute Lymphoblastic Leukemia
Recurrent Childhood Acute Myeloid Leukemia
Recurrent Chronic Lymphocytic Leukemia
Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Recurrent Diffuse Large B-Cell Lymphoma
Recurrent Hodgkin Lymphoma
Recurrent Mantle Cell Lymphoma

Interventions: Drug: Atorvastatin Calcium
Drug: Cyclosporine
Drug: Fludarabine Phosphate
Other: Laboratory Biomarker Analysis
Drug: Mycophenolate Mofetil
Procedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation
Procedure: Peripheral Blood Stem Cell Transplantation
Radiation: Total-Body Irradiation

First Posted Date: 2012-02-06

Last Posted Date: 2020-01-02

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 47

Registration Number: NCT01527045

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
🇺🇸
Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, United States

Cervical Cancer Screening Among Hispanic Women

Not Applicable

Completed

Conditions: Cervical Cancer

Interventions: Behavioral: DVD
Behavioral: Promotora

First Posted Date: 2012-02-03

Last Posted Date: 2018-11-13

Lead Sponsor: Fred Hutchinson Cancer Center

Target Recruit Count: 451

Registration Number: NCT01525433

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy